Who
Young Kwon
Director
Company insider
Files Form 4 as: Director, ADMA Biologics; Chief Financial & Bus. Officer, Momenta Pharmaceuticals.
In numbers
- Trades disclosed
- 239
- Buys
- 2
- Sells
- 42
- Bought
- $198K
- Sold
- $7.6M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 19 Apr 2018
- Last trade
- 9 Feb 2026
- Last filed
- 11 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Feb 2026filed 11 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —10,690 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,730 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,730 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —10,690 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,279 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —10,889 at $0.00 | filing |
| 23 Aug 2024filed 27 Aug 2024 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $1.1M60,000 at $18.26 | filing |
| 26 Feb 2024filed 28 Feb 2024 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,541 at $0.00 | filing |
| 26 Feb 2024filed 28 Feb 2024 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —24,040 at $0.00 | filing |
| 24 Aug 2023filed 24 Aug 2023 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Bought | $98K25,000 at $3.90 | filing |
| 6 Mar 2023filed 8 Mar 2023 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,630 at $0.00 | filing |
| 6 Mar 2023filed 8 Mar 2023 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —25,815 at $0.00 | filing |
| 7 Mar 2022filed 9 Mar 2022 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,172 at $0.00 | filing |
| 7 Mar 2022filed 9 Mar 2022 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —26,586 at $0.00 | filing |
| 25 Oct 2021filed 26 Oct 2021 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Bought | $100K100,000 at $1.00 | filing |
| 15 Oct 2021filed 18 Oct 2021 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,500 at $0.00 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —45,000 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —2,819 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —31,500 | filing |
| 1 Oct 2020filed 1 Oct 2020 | Momenta Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —50,000 | filing |
News
Contrasting Rhythm Pharmaceuticals (NASDAQ:RYTM) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 22 Oct 2026Arcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head SurveyADMA · dailypolitical.com · 18 Oct 2026Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Young Kwon; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.